Healthy Aging Health Center
Midlife Crisis: Transition or Depression?
What's a midlife crisis? It's the stuff of jokes and stereotypes -- the time in life when you do outrageous, impractical things like quit a job impulsively, buy a red sports car, or dump your spouse.
For years, midlife crisis conjured those images. But these days, the old midlife crisis is more likely to be called a midlife transition -- and it's not all bad.
The term crisis often doesn't fit, mental health experts say, because while it can be accompanied by serious depression, it can also mark a period of tremendous growth. The trick, of course, is to realize when the transition is developing into depression so you can get help.
Defining Midlife Crisis
Beginning in the 1980s, the term midlife crisis got a lot of attention, says Dan Jones, PhD, director of the Counseling and Psychological Services Center at Appalachian State University, Boone, N.C. He has researched adult development and transitions.
"It was never a formal diagnostic category," he says of the term midlife crisis. And the age at which midlife crisis strikes can vary, he says. When midlife occurs depends on whom you ask and partly on such factors as how long they expect to live.
A midlife crisis might occur anywhere from about age 37 through the 50s, he says.
By whatever term, the crisis or transition tends to occur around significant life events, he says, such as your youngest child finishing college, or a "zero" birthday announcing to the world that you're entering a new decade.
"The death of parents can be a marker, too, for these midlife events," Jones says.
Midlife Crisis: His vs. Hers
Men and women are equally likely to experience a transition or crisis, Jones says. "But it looks different in both genders," he says.
"The stereotype is a man buys a red sports car," he says. That's not always the case, of course, but Jones says men do seem more intent on wanting to prove something.
Men might gauge their worth by their job performance, he says. They may want to look successful, for instance, even though their achievements don't measure up as they had hoped.
"Women often get validity through relationships," he says, and that's true even if they've had a lifelong career. So at midlife, they are likely to evaluate their performance as a wife, mother, or both.
The Midlife Crisis as a Normal Stage in Life
The midlife transition is looked on, more and more, as a normal part of life. Yale psychologist Daniel Levinson proposed in his well-regarded theory of adult development that all adults go through a series of stages. At the center of his theory is the life structure, which is described as the underlying pattern of a person's life at any particular time.
For many people, the life structure involves mainly family and work, but it can also include religion and economic status, for instance. According to his theory, the midlife transition is simply another, normal transition to another stage of life.
Indication
Uroxatral® (alfuzosin HCl 10 mg extended-release tablets) is an alpha1-blocker for the treatment of the signs and symptoms of BPH.
Important Safety Information
Do not take UROXATRAL if you have liver problems or if you are taking antifungal drugs like ketoconazole or itraconazole, or HIV drugs like ritonavir.
UROXATRAL can cause a sudden drop in blood pressure, especially when starting treatment. This may lead to fainting, dizziness, and lightheadedness. Do not drive, operate machinery, or do any dangerous activity until you know how UROXATRAL will affect you. This is especially important if you already have a problem with low blood pressure or take medicines to treat high blood pressure. There may be an increased risk of low blood pressure and fainting when taking UROXATRAL in combination with blood pressure medication or nitrates, or erectile dysfunction medication.
If considering cataract surgery (clouding of the eyes), tell your eye surgeon that you are currently taking UROXATRAL or have previously been treated with an alpha-blocker.
Before taking UROXATRAL, tell your doctor if you have kidney problems.
Also, tell your doctor if you or any family member(s) have or take medications for a rare heart condition known as congenital prolongation of the QT interval.
BPH and prostate cancer can cause the same symptoms. However, UROXATRAL is not a treatment for prostate cancer.
The most common side effects with UROXATRAL are dizziness, upper respiratory tract infection, headache, and tiredness.
Please see UROXATRAL full prescribing information.
VIVELLE-DOT (estradiol transdermal system) IS AVAILABLE BY PRESCRPTION ONLY.
INDICATION
Vivelle-Dot is used after menopause to: reduce moderate to severe hot flashes; treat moderate to severe dryness, itching and burning in or around the vagina; help reduce your chances of getting osteoporosis (thin weak bones); and treat certain conditions in which a young woman's ovaries do not produce enough estrogens naturally. Vivelle-Dot 0.025 mg/day is only used to prevent osteoporosis from menopause. If you use Vivelle-Dot only to treat your dryness, itching, and burning in and around your vagina or if you use Vivelle-Dot only to prevent osteoporosis from menopause, talk with your healthcare professional about whether a different treatment or medicine without estrogens might be better for you.
IMPORTANT SAFETY INFORMATION
Estrogens increase the chances of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are taking estrogens. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb).
Do not use estrogens with or without progestins to prevent heart disease, heart attacks, or strokes. Using estrogens with or without progestins may increase your chances of getting heart attacks, strokes, breast cancer, and blood clots. Using estrogens with progestins may increase your risk of dementia (decline in memory and thinking skills).
Vivelle-Dot should not be used if you have unusual vaginal bleeding; currently have or have had certain cancers, including cancer of the breast or uterus; had a stroke or heart attack in the recent past (for example, in the past year); currently have or have had blood clots; currently have or have had liver problems; or think you may be, or know that you are, pregnant.
The most common side effects that may occur with Vivelle-Dot are headache, breast tenderness, and back pain.
You and your healthcare professional should talk regularly about whether you still need treatment with Vivelle-Dot.
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-1088.
Please see Full Prescribing Information for Vivelle-Dot.


